PFE

Pfizer, Inc.

26.24 USD
+0.24 (+0.92%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Pfizer, Inc. stock is down -4.09% since 30 days ago. The next earnings date is May 1, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 56% of the previous 49 April’s closed higher than March. In the last 10 Unusual Options Trades, there were 8 PUTs, 2 CALLs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
22 Apr 18:15 21 Jun, 2024 26.00 PUT 420 26963
22 Apr 18:17 17 Jan, 2025 25.00 CALL 100 30535
22 Apr 18:30 18 Oct, 2024 25.00 PUT 316 2041
22 Apr 18:43 21 Jun, 2024 26.00 CALL 232 9724
22 Apr 18:51 17 Jan, 2025 25.00 PUT 457 59258
22 Apr 19:08 19 Jul, 2024 26.00 PUT 1288 11236
22 Apr 19:08 19 Jul, 2024 26.00 PUT 247 11236
22 Apr 19:08 21 Jun, 2024 26.00 PUT 1288 26963
22 Apr 19:08 21 Jun, 2024 26.00 PUT 274 26963
22 Apr 19:09 17 Jan, 2025 30.00 PUT 60 19904

About Pfizer, Inc.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health. The company also provides biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Cibinqo brands.

  • Cantor Fitzgerald
    Thu Apr 18, 10:01
    buy
    confirm
  • Cantor Fitzgerald
    Mon Apr 15, 10:31
    buy
    confirm
  • Cantor Fitzgerald
    Fri Apr 5, 09:33
    buy
    confirm
  • Cantor Fitzgerald
    Mon Apr 1, 08:39
    buy
    confirm